Speedel Group Holds Annual R&D Day

BASEL, SWITZERLAND--(Marketwire - March 31, 2008) - - Extensive data supporting mature and diverse pipeline - Basel/Switzerland and Bridgewater NJ/USA, 31 March 2008 Speedel (SWX: SPPN) today holds its annual Research & Development Day. The event is being held in Zürich, and attended by over 40 investors, analysts and media. The programme highlights Speedel's achievement in building a mature and diverse pipeline, targeting therapeutic areas with significant unmet medical need and high commercial potential. For the first time Speedel will present results on a new mode of action in cardiovascular treatment, that reduces the production of aldosterone.